Research Article Autoimmunity Microbiology Open Access | 10.1172/JCI163239 Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege 1 Feil Family Brain and Mind Research Institute, 2 Jill Roberts Institute for …
University City District (UCD) is a West Philadelphia non-profit organization. We maintain websites (Collectively, UCD sites) in furtherance of advancing our mission of changing places and changing lives within our coverage area. Websites that are the property of UCD include: phi…
Systemic and Local Lipids in Nonhuman Primates With Drusen and Age-Related Maculopathies. Invest Ophthalmol Vis Sci. 2025 Sep 02; 66(12):41. Villafuerte-Trisolini C, Le SM, Sin TN, Huynh L, Gong M, Shen T, Heo J, Roszak K, Raposo AS, Graham J, Havel P , Choy K, Farsiu S, Thomasy …
1. Introduction The prevalence of type-2 diabetes (T2D) is rising globally due to obesity and physical inactivity on top of genetic predispositions, among other factors. Cardiovascular diseases (CVD) are the leading cause of mortality and morbidity in diabetic patients [ 1 , 2 ].…
What is User Centered Design (UCD)? — updated 2026 | IxDF User Centered Design (UCD) Your constantly-updated definition of User Centered Design (UCD) and collection of videos and articles. Be a conversation starter : Share this page and inspire others! 1,603 Shares Save What is U…
What is User Centered Design (UCD)? — updated 2026 | IxDF User Centered Design (UCD) Your constantly-updated definition of User Centered Design (UCD) and collection of videos and articles. Be a conversation starter : Share this page and inspire others! 1,603 Shares Save What is U…
Introduction Background Research estimates that the lifetime prevalence of psychotic disorder diagnoses is approximately 1.5%, and the prevalence of psychotic symptoms is between 4.2% and 17.5% []. California, the most populous and second most diverse state in the United States […
Abstract OBJECTIVE The efficacy of liraglutide, a human glucagon-like peptide-1 (GLP-1) analog, to prevent or delay diabetes in UCD-T2DM rats, a model of polygenic obese type 2 diabetes, was investigated. RESEARCH DESIGN AND METHODS At 2 months of age, male rats were divided into…
Design of Interactive Medical Devices: Feedback and Its Improvement Yunqiu Li, Patrick Oladimeji Dominic Furniss, Chris Vincent Carlos Monroy, Abigail Cauchi, Harold Thimbleby Ann Blandford Computer Science Department UCLIC, University College London Swansea University, Swansea, …
Abstract There is a need to identify strategies for type 2 diabetes prevention. Therefore, we investigated the efficacy of pioglitazone and alogliptin alone and in combination to prevent type 2 diabetes onset in UCD-T2DM rats, a model of polygenic obese type 2 diabetes. At 2 mont…
Unicode® Technical Standard #39 Unicode Security Mechanisms Summary Because Unicode contains such a large number of characters and incorporates the varied writing systems of the world, incorrect usage can expose programs or systems to possible security attacks. This document spec…
Unicode® Technical Standard #39 Unicode Security Mechanisms Summary Because Unicode contains such a large number of characters and incorporates the varied writing systems of the world, incorrect usage can expose programs or systems to possible security attacks. This document spec…
UTS #39: Unicode Security Mechanisms Technical Reports Unicode® Technical Standard #39 Unicode Security Mechanisms Version 17.0.0 Editors Mark Davis ( markdavis@google.com ), Michel Suignard ( michel@suignard.com Date 2025-09-04 This Version Previous Version Latest Version Latest…
UTS #39: Unicode Security Mechanisms Technical Reports Unicode® Technical Standard #39 Unicode Security Mechanisms Version 17.0.0 Editors Mark Davis ( markdavis@google.com ), Michel Suignard ( michel@suignard.com Date 2025-09-04 This Version Previous Version Latest Version Latest…
UTS #39: Unicode Security Mechanisms Technical Reports Unicode® Technical Standard #39 Unicode Security Mechanisms Version 16.0.0 Editors Mark Davis ( markdavis@google.com ), Michel Suignard ( michel@suignard.com Date 2024-09-03 This Version Previous Version Latest Version Latest…